Artemisia Vulgaris Pollen Extract

4 trials VVarious

Filter these 4 trials by condition, phase, country and more.

Open in Search →

4 Registered trials

0 Recruiting

4 Completed trials

2 Sponsors

7 Countries

Phase III

Phase II/III

Phase III: 1 Phase II/III: 3

Sponsors using this IMP

ROXALL Medizin GmbH 3 HAL Allergy B.V. 1

All trials

4 total

Phase II-III study to assess the efficacy and safety of subcutaneous cluster-immunotherapy in patients suffering from Olea europaea pollen a… Ended

2024-511383-88-00 Phase II/III 1 country ROXALL Medizin GmbH
A Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Study to Assess the Efficacy of PURETHAL Mites Mixture 50,000 AUeq/mL Subcutane… Ended

2023-504942-75-01 Phase III 6 countries HAL Allergy B.V.
Phase II-III study to assess the efficacy and safety of sublingual immunotherapy in patients suffering from grass pollen allergy Ended

2023-505880-35-00 Phase II/III 1 country ROXALL Medizin GmbH
Phase II-III study to assess the efficacy and safety of sublingual immunotherapy in patients suffering from birch pollen allergy Ended

2023-505567-37-00 Phase II/III 1 country ROXALL Medizin GmbH

Showing 1–4 of 4 trials

← All drugs A–Z